0:00
/
Generate transcript
A transcript unlocks clips, previews, and editing.

A Fed Hike, a War, and a Bond Yield Not Seen Since 2007. Here's the SGX Domino Effect.

Kevin Warsh raised rates for the first time since 2023. Here's how that turns into your SORA rate and DBS's margins.

My phone was buzzing all morning with Fed headlines, so I sat down and traced the whole chain, from Kevin Warsh’s rate hike, through a 10-year Treasury yield sitting at its highest close since 2007, all the way to what it means for SORA and your bank stock back home. Everyone wants to jump straight to “banks in trouble,” but I checked DBS’s actual numbers against UOB Kay Hian’s Sell call this week, and the picture is messier and more interesting than the headline. Margins are drifting, capital and loan quality are not. If you are holding CPF or SRS money in bank shares, this is the mechanism you need to understand before the next headline lands.

Key takeaways:

  • Fed hiked a quarter point, first since 2023, citing a stronger economy, sticky inflation, and geopolitical risk

  • 10-year US Treasury yield closed above 5%, highest since 2007, partly on Middle East tensions and heavy tech sector borrowing

  • UOB Kay Hian downgraded DBS to Sell, target S$74.70, tied to inflation and Middle East risk

  • DBS Q2 net interest margin eased to 1.87% from 1.89%, CET1 ratio at 16.6%, NPL ratio flat at 1%, allowance coverage at 130%

  • Watch the Iran war and US yields as the next link in the chain toward SORA and REIT refinancing costs

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.


Iggy’s Forensic Disclaimer

This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.

Discussion about this video

User's avatar

Ready for more?